Experimental drug aims to attack cancer before surgery
NCT ID NCT05845307
Summary
This study aimed to test if a drug called TTI-101 could reduce the size of head and neck cancers before patients had standard surgery. The trial planned to give the drug for a short period before the planned operation to see if it made the tumors easier to remove. However, the study was withdrawn by the organizers before any patients were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.